Synergistic Inhibition of Acetylcholinesterase by Alkaloids Derived from Stephaniae Tetrandrae Radix, Coptidis Rhizoma and Phellodendri Chinensis Cortex

Alkaloids having acetylcholinesterase (AChE) inhibitory activity are commonly found in traditional Chinese medicine (TCM); for example, berberine from Coptis chinensis, galantamine from Lycoris radiata, and huperzine A from Huperzia serrata. In practice of TCM, Stephaniae Tetrandrae Radix (STR) is often combined with Coptidis Rhizoma (CR) or Phellodendri Chinensis Cortex (PCC) as paired herbs during clinical application. Fangchinoline from STR and coptisine and/or berberine from CR and/or PCC are active alkaloids in inhibiting AChE. The traditional usage of paired herbs suggests the synergistic effect of fangchinoline–coptisine or fangchinoline–berberine pairing in AChE inhibition. HPLC was applied to identify the main components in herbal extracts of STR, CR, and PCC, and the AChE inhibition of their main components was determined by Ellman assay. The synergism of herb combination and active component combination was calculated by median-effect principle. Molecular docking was applied to investigate the underlying binding mechanisms of the active components with the AChE protein. It was found that fangchinoline showed AChE inhibitory potency; furthermore, fangchinoline–coptisine/berberine pairs (at ratios of 1:5, 1:2, 1:1, and 2:1) synergistically inhibited AChE; the combination index (CI) at different ratios was less than one when Fa = 0.5, suggesting synergistic inhibition of AChE. Furthermore, the molecular docking simulation supported this enzymatic inhibition. Therefore, fangchinoline–coptisine/berberine pairs, or their parental herbal mixtures, may potentially be developed as a possible therapeutic strategy for Alzheimer’s patients.

[1]  K. Zheng,et al.  The membrane permeability of Astragali Radix-derived formononetin and calycosin is increased by Angelicae Sinensis Radix in Caco-2 cells: a synergistic action of an ancient herbal decoction Danggui Buxue Tang. , 2012, Journal of pharmaceutical and biomedical analysis.

[2]  V. Cavallaro,et al.  Send Orders of Reprints at Reprints@benthamscience.net Natural Ache Inhibitors from Plants and Their Contribution to Alzheimer's Disease Therapy , 2022 .

[3]  M. Wink,et al.  Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer’s Disease Target , 2016, Molecules.

[4]  M. Chung,et al.  Anti-inflammatory effects of fangchinoline and tetrandrine. , 2000, Journal of ethnopharmacology.

[5]  Qi-yi Tang,et al.  Data Processing System (DPS) software with experimental design, statistical analysis and data mining developed for use in entomological research , 2013, Insect science.

[6]  T. Dong,et al.  Verification of the formulation and efficacy of Danggui Buxue Tang (a decoction of Radix Astragali and Radix Angelicae Sinensis): an exemplifying systematic approach to revealing the complexity of Chinese herbal medicine formulae , 2007, Chinese medicine.

[7]  D. Westaway,et al.  Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. , 2004, Journal of psychiatry & neuroscience : JPN.

[8]  G. Zeni,et al.  Ebselen inhibits the activity of acetylcholinesterase globular isoform G4 in vitro and attenuates scopolamine‐induced amnesia in mice , 2018, Journal of cellular biochemistry.

[9]  T. Arendt,et al.  The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease , 2006, Journal of Neural Transmission.

[10]  Liang Shen,et al.  Berberine: A Potential Multipotent Natural Product to Combat Alzheimer’s Disease , 2011, Molecules.

[11]  K. Tsim,et al.  Acetylcholinesterase Protein Level Is Preserved in the Alzheimer's Brain , 2014, Journal of Molecular Neuroscience.

[12]  L. Descarries,et al.  The acetylcholine innervation of cerebral cortex: new data on its normal development and its fate in the hAPPSW,IND mouse model of Alzheimer’s disease , 2004, Journal of Neural Transmission.

[13]  V. Pavlov,et al.  Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway , 2009, Brain, Behavior, and Immunity.

[14]  G. K. Chu,et al.  A Chinese herbal decoction, Danggui Buxue Tang, prepared from Radix Astragali and Radix Angelicae Sinensis stimulates the immune responses. , 2006, Planta medica.

[15]  E. Shaw,et al.  Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: A pilot study , 2012, Pediatric blood & cancer.

[16]  Yun Tang,et al.  Investigation of the binding mode of (−)-meptazinol and bis-meptazinol derivatives on acetylcholinesterase using a molecular docking method , 2006, Journal of molecular modeling.

[17]  I. Churcher.  Tau therapeutic strategies for the treatment of Alzheimer's disease. , 2006, Current topics in medicinal chemistry.

[18]  H. Soreq,et al.  MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. , 2009, Immunity.

[19]  Soon-ok Cho,et al.  Protective effect of fangchinoline on cyanide-induced neurotoxicity in cultured rat cerebellar granule cells , 2002, Archives of pharmacal research.

[20]  Cheng-Wei Lu,et al.  Fangchinoline inhibits glutamate release from rat cerebral cortex nerve terminals (synaptosomes) , 2009, Neurochemistry International.

[21]  E. Giacobini.  Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease , 2003, Neurochemical Research.

[22]  J. Choi,et al.  Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids. , 2009, Biological & pharmaceutical bulletin.

[23]  Z. Cai,et al.  Role of berberine in Alzheimer’s disease , 2016, Neuropsychiatric disease and treatment.

[24]  M. Vandewoude,et al.  DONEPEZIL-RELATED TOXIC HEPATITIS , 2008, Acta clinica Belgica.

[25]  S. Brimijoin,et al.  Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex , 2003, Neurobiology of Aging.

[26]  E. Barnard,et al.  An asymmetric form of muscle acetylcholinesterase contains three subunit types and two enzymic activities in one molecule. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Marcela Colombres,et al.  Structure and function of amyloid in Alzheimer's disease , 2004, Progress in Neurobiology.

[28]  M. Wink,et al.  Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[29]  Claudia Linker,et al.  Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme , 1996, Neuron.

[30]  Anthony J Turner,et al.  Journal of Neurochemistry special issue on Alzheimer’s disease: ‘amyloid cascade hypothesis – 20 years on’ , 2012, Journal of neurochemistry.

[31]  Yifan Han,et al.  Synergistic Inhibition on Acetylcholinesterase by the Combination of Berberine and Palmatine Originally Isolated from Chinese Medicinal Herbs , 2014, Journal of Molecular Neuroscience.

[32]  Xiao-Ping Wang,et al.  Alzheimer’s disease: epidemiology, genetics, and beyond , 2008, Neuroscience bulletin.

[33]  T. Chou.  Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.

[34]  Shuo Li,et al.  Acetylcholinesterase inhibitory activity of the total alkaloid from traditional Chinese herbal medicine for treating Alzheimer’s disease , 2011, Medicinal Chemistry Research.

[35]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[36]  N. Inestrosa,et al.  Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-β-peptides , 1995, Neuroscience Letters.

[37]  Chih-Hsin Tang,et al.  Berberine suppresses neuroinflammatory responses through AMP‐activated protein kinase activation in BV‐2 microglia , 2010, Journal of cellular biochemistry.

[38]  N. Ip,et al.  Plant alkaloids as drug leads for Alzheimer's disease , 2015, Neurochemistry International.

[39]  C. Che,et al.  Chemical and Biological Differentiation of Cortex Phellodendri Chinensis and Cortex Phellodendri Amurensis , 2010, Planta medica.

[40]  Hong-Qi Yang,et al.  Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease , 2013, Translational Neurodegeneration.

[41]  N. Inestrosa,et al.  Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. , 1997, Journal of molecular biology.

[42]  Z. Cai,et al.  Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases. , 2018, Current Alzheimer research.

[43]  H. Soreq,et al.  Acetylcholinesterase: old questions and new developments , 2013, Front. Mol. Neurosci..

[44]  Seema Joshi,et al.  Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone , 2018, Comput. Biol. Chem..

[45]  Amitava Das,et al.  Role of molecular isoforms of acetylcholinesterase in learning and memory functions , 2005, Pharmacology Biochemistry and Behavior.

[46]  J. Sangha,et al.  Liuwei Dihuang (LWDH), a Traditional Chinese Medicinal Formula, Protects against β-Amyloid Toxicity in Transgenic Caenorhabditis elegans , 2012, PloS one.

[47]  R. Choi,et al.  A Chinese Herbal Decoction, Danggui Buxue Tang, Stimulates Proliferation, Differentiation and Gene Expression of Cultured Osteosarcoma Cells: Genomic Approach to Reveal Specific Gene Activation , 2011, Evidence-based complementary and alternative medicine : eCAM.

[48]  S. Senapati,et al.  Effects of Huanglian-Jie-Du-Tang and Its Modified Formula on the Modulation of Amyloid-β Precursor Protein Processing in Alzheimer's Disease Models , 2014, PloS one.

[49]  J. Sussman,et al.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. , 1999, Structure.